| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5592640 | Cardiovascular Revascularization Medicine | 2017 | 22 Pages |
Abstract
Despite multiple comorbidities in a selected TAVR-population and the use of contrast media, TAVR did not impair renal function in a majority of patients, with a significant proportion of them rather having acute renal function improvement.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Bruno L.R. Faillace, Henrique B. Ribeiro, Carlos M. Campos, Adriano A.M. Truffa, Fernando L. Bernardi, Marcos D.P. Oliveira, José Jr, Julio F. Marchini, Flavio Tarasoutchi, Pedro A. Lemos,